Statins: new American guidelines for prevention of cardiovascular disease
- 1 November 2013
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 382 (9907), 1762-1765
- https://doi.org/10.1016/s0140-6736(13)62388-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A Trial-Based Approach to Statin GuidelinesJAMA, 2013
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Rosuvastatin in Older Patients with Systolic Heart FailureThe New England Journal of Medicine, 2007
- Use and Misuse of the Receiver Operating Characteristic Curve in Risk PredictionCirculation, 2007
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenThe New England Journal of Medicine, 2005
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaThe New England Journal of Medicine, 1995
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989